Rancho Santa Fe Bio is a clinical-stage, platform company developing treatments for soft tissue calcification disorders. Our leading drug, ataciguat will be provided to all patients with CAVS and AVS globally. Rancho Santa Fe Bio, Inc is an innovative small molecule technology company focused on the development of novel treatments for acute, chronic conditions.

TETmedical, Inc. (Tethered Enzyme Technologies) is a clinical stage platform nanomedicine company focused on in vitro diagnostics that enable insights for high-consequence disease decision making. TET emerged out of groundbreaking innovations originating at Cornell University. a patented “TET nanobot”, consisting of thousands of enzymes tethered to a silica nanoparticle. TETmedical’s first product is the NSE-FAST (Neuron Specific Enolase Functional Activity Stroke Test), the first in-vitro diagnostic for brain injury from stroke.

Personalized Digital therapies for inflammatory chronic conditions

Ampersand Health works alongside world-renowned researchers, clinicians and patient groups, to create industry-leading personalised digital therapies that help prolong periods of remission, and provide support in the self-management of long-term conditions.

Autism is a serious developmental disorder that lasts a lifetime. The rates of autism continue to rise, the cause remains unknown and there is no cure. We believe that children on the autism spectrum can lead fulfilling and productive lives.

That is why we are developing Cognilum, an innovative solution to permanently reduce a child's autism symptoms. It is a therapeutic wearable device. It combines non-invasive brain stimulation with infrared light, EEG sensors and an AI personalization platform.